The reverse split is a last-resort compliance measure that does not fix the company's fundamental issues—widening losses, core pharma revenue decline, massive dilution from prior stock-for-asset acquisitions and private placements, and potential Nasdaq delisting. Monitor whether the stock holds above $1 post-split; failure to maintain compliance could trigger delisting proceedings.
Price Chart
Executive Summary
BGM Group Ltd. announced a 30-for-1 reverse share split, effective October 1, 2026, to regain compliance with Nasdaq's minimum bid price requirement. The consolidation reduces outstanding Class A shares from ~380.6M to ~12.7M, a purely mechanical adjustment that does not change the company's fundamentals or address its severe financial deterioration.
Key Facts
- 30-for-1 reverse share split of all Class A, Class B, and preferred shares, effective October 1, 2026.
- Outstanding Class A shares reduced from 380,623,358 to 12,687,445 post-consolidation.
- Authorized share capital increased to $15,090,000, split into 5B Class A, 20M Class B, and 10M preferred shares at $0.003 par value each.
- Share consolidation approved by shareholders on September 5, 2026, and board on August 11, 2026.
- Company faces Nasdaq delisting risk from bid-price deficiency, as noted in the prior 20-F filing.
Financial Impact
No change in market cap or enterprise value; reverse split is mechanical. However, the action signals ongoing Nasdaq compliance risk and does not address the underlying financial deterioration (net loss widened to $20.2M in FY2025, core pharma revenue declined 6%).
Risk Factors
- Nasdaq delisting if the post-split share price fails to sustain above $1.00 for 30 consecutive trading days.
- Continued shareholder dilution from authorized but unissued shares (5B Class A shares authorized post-split).
- No improvement in underlying business fundamentals—net loss widened to $20.2M in FY2025 and core pharmaceutical revenue declined 6%.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-110425 |
| Document: 0001104659-26-110425-index-headers.html | 0001104659-26-110425 |
| Document: 0001104659-26-110425-index.html | 0001104659-26-110425 |
| Document: 0001104659-26-110425.txt | 0001104659-26-110425 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 24, 2026 4w ago | 6-K | $0.2400 $0.2617 | ▼ −9.03% | ▼ −10.50% | $8.98 (−3639.58%) |
Aug 28, 2026 8w ago | 6-K | $0.3275 $0.2440 | ▲ +25.50% | ▲ +25.76% | $8.98 (−2640.46%) |
Jul 21, 2026 14w ago | 20-F | $0.3000 $0.2880 | ▲ +4.00% | ▲ +6.56% | $8.98 (−2891.67%) |
Jun 9, 2026 20w ago | 6-K | $0.3401 $0.3332 | ▲ +2.03% | ▲ +3.48% | $8.98 (−2538.93%) |
May 18, 2026 23w ago | 6-K | $0.2750 $0.4441 | ▼ −61.49% | ▼ −59.91% | $8.98 (−3163.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers